Abstract
Despite multiple advances in the management of retinoblastoma, enucleation remains an essential therapeutic modality. We studied patients who underwent enucleation at the King Hussein Cancer Center in Jordan. We retrospectively reviewed medical records of children with retinoblastoma who were treated at our center from June 2002 to February 2008. Twenty-eight eyes from 27 patients were enucleated. Median age at diagnosis was 1.1 years (range, 0.3–6.3 years). Twenty-six eyes (93%) had advanced disease (RE groups IV and V). Seventeen patients (61%) had unilateral retinoblastoma, and 11 (39%) had bilateral retinoblastoma. The median time from diagnosis to enucleation was 0.45 months (range, 0–45 months; mean, 4.4 months) and was longer for patients with bilateral retinoblastoma (median, 2.2 vs. 0.2 months; P = 0.034). Twenty enucleated eyes (71%) did not show high-risk pathologic features. Seventeen eyes with advanced intraocular disease were enucleated at the time of presentation, whereas chemoreduction was attempted for the other 19 eyes with advanced intraocular disease. Enucleation was then recommended for nine (47%) of those eyes. Enucleation at the time of diagnosis was feasible for most patients with advanced disease. Attempted salvage of eyes with advanced disease is justified, particularly in patients with bilateral disease. We were able to salvage almost half of these eyes. We hope our study provides new insights for counseling patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chintagumpala M, Chevez-Barrios P, Paysse EA et al (2007) Retinoblastoma: review of current management. Oncologist 12(10):1237–1246
Wilson MW, Haik BG, Rodriguez-Galindo C (2006) Socioeconomic impact of modern multidisciplinary management of retinoblastoma. Pediatrics 118(2):e331–e336
Barr R, Ribeiro R, RB A (2002) Pediatric oncology in countries with limited resources. In: Pizzo P, Poplack D (eds) Principles and practice of pediatric oncology. Lippincott Williams and Wilkins, Philadelphia, pp 1541–1552
Kivelä T (2009) The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br Med J 93(9):1129
Leander C, Fu LC, Pena A et al (2007) Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 49(6):817–819
Qaddoumi I, Nawaiseh I, Mehyar M et al (2008) Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer 51:241–244
Suzuki S, Kaneko A (2004) Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 9(1):1–6
Al-Qudimat MR, Day S, Almomani T et al (2009) Clinical nurse coordinators: a new generation of highly specialized oncology nursing in Jordan. J Pediatr Hematol Oncol 31(1):38–41
Chantada GL, Dunkel IJ, de Davila MT et al (2004) Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol 88(8):1069–1073
Sastre X, Chantada GL, Doz F et al (2009) Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med 133(8):1199–1202
Shields CL, Honavar SG, Meadows AT et al (2002) Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 120(12):1653–1658
Abramson DH, Gamell LS, Ellsworth RM et al (1994) Unilateral retinoblastoma: new intraocular tumours after treatment. Br J Ophthalmol 78(9):698–701
Chantada G, Doz F, Antoneli CB et al (2006) A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47(6):801–805
Shields CL, Mashayekhi A, Au AK et al (2006) The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 113(12):2276–2280
Chantada GL, Doz F, Orjuela M et al (2008) World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer 50(3):692–694
Shields CL, Shields JA, Baez KA et al (1993) Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 77(9):544–548
Eagle RC Jr (2009) High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med 133(8):1203–1209
Acknowledgment
The authors would like to thank David Galloway for editing this manuscript. This research was financially supported by Research to Prevent Blindness, Inc., New York, New York; St Giles Foundation, New York, New York; American Lebanese Syrian Associated Charities (ALSAC), Memphis, TN; and King Hussein Cancer Foundation (KHCF), Amman, Jordan.
Conflicts of interest statement
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sultan, I., Wilson, M.W., Nawaiseh, I. et al. Enucleation for retinoblastoma: the experience of a single center in Jordan. Int Ophthalmol 30, 407–414 (2010). https://doi.org/10.1007/s10792-010-9370-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-010-9370-3